Co-Authors
This is a "connection" page, showing publications co-authored by SANJAY SHETE and EHAB Y HANNA.
Connection Strength
2.097
-
Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Cancer Med. 2023 01; 12(1):569-583.
Score: 0.217
-
Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Sci Rep. 2022 04 22; 12(1):6662.
Score: 0.215
-
Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors. Head Neck. 2022 04; 44(4):952-963.
Score: 0.211
-
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. Cancer. 2021 12 01; 127(23):4470-4480.
Score: 0.204
-
Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2021 07 01; 147(7):615-623.
Score: 0.203
-
Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck. Cancer. 2020 12 01; 126(23):5124-5136.
Score: 0.192
-
Genome-wide association study identifies genes associated with neuropathy in patients with head and neck cancer. Sci Rep. 2018 06 08; 8(1):8789.
Score: 0.164
-
Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS One. 2017; 12(7):e0180396.
Score: 0.154
-
Cohort study of oncologic emergencies in patients with head and neck cancer. Head Neck. 2017 06; 39(6):1195-1204.
Score: 0.151
-
Genome-wide association study suggests common variants within RP11-634B7.4 gene influencing severe pre-treatment pain in head and neck cancer patients. Sci Rep. 2016 Sep 27; 6:34206.
Score: 0.146
-
Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain. 2014 Oct; 15(10):1015-22.
Score: 0.125
-
Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors. Head Neck. 2024 03; 46(3):627-635.
Score: 0.060
-
Neuropathic pain prevalence and risk factors in head and neck cancer survivors. Head Neck. 2022 12; 44(12):2820-2833.
Score: 0.055